SRS Capital Advisors »

Lyell Immunopharma shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Lyell Immunopharma (LYEL) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Lyell Immunopharma

Tip: Access up to 7 years of quarterly data

All positions including Lyell Immunopharma held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lyell Immunopharma by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $132 95 1.39
2024-06-30 $137 95 1.45

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Mid Cap Etf (VO)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Ishares Tr Ishs 1-5yr Invs (IGSB)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Schwab Strategic Tr Us Tips Etf (SCHP)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Ishares Tr Core Us Aggbd Et (AGG)
Dimensional Etf Trust Core Fixed Incom (DFCF)
First Tr Exchange-traded Cap Strength Etf (FTCS)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Apple (AAPL)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Lyell Immunopharma

MWG Management
Orland Properties
BlackRock
Vanguard Group
Foresite Capital Management IV
WuXi AppTec
venBio Partners
T. Rowe Price Associates
Alphabet
Geode Capital Management
Citadel Advisors
State Street Corporation
OrbiMed Advisors
Sc China Holding
MIC Capital Management UK

View all funds holding Lyell Immunopharma